Can You Take Wegovy If You Have GERD?

Wegovy (semaglutide) slows the rate at which food leaves the stomach, a mechanism that can worsen or trigger acid reflux in people who are already prone to it.
GERD is not listed as an absolute contraindication in the Wegovy SmPC, but active or poorly controlled reflux warrants a careful clinical assessment before starting treatment.
Losing weight itself tends to reduce GERD symptoms over time, since excess abdominal weight increases pressure on the lower oesophageal sphincter.
Gastrointestinal side effects, including nausea, indigestion and burping, are among the most common reported with semaglutide, particularly in the early weeks of treatment.

If you have GERD and are considering Wegovy for weight management, the short answer is: it depends on how well your reflux is controlled and what your prescriber finds when they review your full picture. Semaglutide slows gastric emptying, which can aggravate acid reflux symptoms in some people, so GERD is a factor a clinician needs to weigh carefully before prescribing — not a straightforward disqualifier. These are prescription-only medicines, and whether treatment is right for you is a decision made with a qualified prescriber, not a checklist.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and guidance say about reflux, gastric emptying and semaglutide treatment

Imagine waking up and reaching for your antacids before you've even had breakfast

That's the daily reality for many people living with GERD, and the thought of adding a medicine that slows your digestion further understandably raises questions. Wegovy works partly by delaying gastric emptying — food moves through the stomach more slowly, which helps produce the feeling of fullness that supports weight loss. For someone whose reflux is already caused or worsened by food sitting in the stomach too long, that mechanism can tip the balance.

In clinical practice, this doesn't mean people with reflux cannot use semaglutide. It means the decision needs to be made by a prescriber who knows whether your GERD is mild and well-managed on a proton pump inhibitor, or whether it's active, erosive, or complicated by other conditions. The NHS semaglutide medicines page lists indigestion, acid reflux and burping among the common side effects, which is worth factoring in before you start. A prescriber will also want to know about any history of gastroparesis, oesophagitis or Barrett's oesophagus, because those shift the risk calculation.

The scenario most likely to be a problem: starting at too fast a dose escalation when your gut is already reactive. The most manageable scenario: mild, controlled reflux where weight loss itself may, over weeks and months, ease the pressure on your lower oesophagus.

How weight loss and semaglutide can actually pull in opposite directions on GERD

Here's something that doesn't always get explained clearly. Carrying excess weight, particularly around the abdomen, physically increases pressure on the lower oesophageal sphincter, the muscle that stops stomach acid travelling upwards. That's one reason obesity and GERD so often overlap. Sustained weight loss genuinely reduces that pressure, and for many people, their reflux symptoms improve meaningfully as weight comes down.

So there's a reasonable argument that, for someone with GERD driven or worsened by their weight, successful treatment with semaglutide could, over time, help the very condition that makes starting it complicated. The catch is the short term. In the early weeks of dose escalation, nausea, indigestion and reflux-like symptoms are common with Wegovy. Getting through that window, especially if your stomach is already sensitive, takes careful management: eating smaller portions, avoiding lying flat after food, keeping fatty or spicy meals out of the rotation, and making sure your reflux medication is doing its job. It's also worth knowing that stopping Wegovy is something people do consider, particularly if side effects prove difficult to manage in those early weeks.

If you're also exploring the broader picture of what treatment might suit you, our Wegovy treatment page covers how semaglutide works and what the prescribing process involves. For context on how costs sit, our Wegovy prices page sets that out plainly, one price that includes consultation, prescription and aftercare, nothing hidden.

What a prescriber needs to know before starting Wegovy if you have GERD

This is where the detail matters. A responsible prescriber (our clinical team reviews every consultation personally, not via an automated system) will ask about the nature and severity of your reflux, what you're currently taking to manage it, and whether you've ever been investigated for complications. That's not bureaucracy; it's the difference between a safe, appropriate prescription and one that makes life worse.

Specific things that will influence the decision: whether your GERD is controlled on medication or symptomatic despite treatment; whether you've had an endoscopy showing erosive disease or Barrett's changes; whether you have any overlap with conditions like IBS (you can read more about Wegovy and IBS in a separate guide) or gallstones, which have their own implications for whether Wegovy is suitable, and which also affect GI tolerability. People with a history of certain serious upper GI problems may not be suitable candidates, and that's a conversation to have openly rather than to work around.

The MHRA's Yellow Card scheme is how patients and clinicians report suspected side effects, including unexpected worsening of reflux, worth knowing about if you do start treatment. And if symptoms become severe or change character, particularly any difficulty swallowing, chest pain or black stools, those warrant prompt medical attention rather than waiting for your next prescription review.

Questions about age eligibility, or concerns about other conditions alongside GERD, are common, and if you have an autoimmune condition such as lupus you can find out more about whether Wegovy is appropriate when lupus is part of the picture. Our FAQs cover a range of situations, and the clinical team behind every num prescription brings exactly this kind of case-by-case clinical thinking. If you'd like to find out whether Wegovy is appropriate for your specific situation, the right starting point is a free consultation where a prescriber reviews your health in full.

Check your eligibility by starting your free consultation, our prescribers will take your GERD history into account alongside everything else.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions